| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |